Complicações cardiovasculares associadas ao COVID-19
Palavras-chave:
Coronavírus; sistema cardiovascular; pandemia.Resumo
A infecção respiratória desencadeada pelo Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) foi reportada inicialmente na cidade de Wuhan, China em dezembro de 2019 e em março de 2020 foi declarada como pandemia pela Organização Mundial de Saúde. A Coronavirus Disease 19 (COVID-19) é caracterizada por apresentar alta infectividade, alta capacidade de transmissão, mesmo durante a fase assintomática, e virulência relativamente baixa. Esta patologia gera repercussões primárias sobre o sistema respiratório, no entanto, pode gerar impactos sobre outros órgãos incluindo o sistema cardiovascular. Dentre as complicações cardiovasculares associadas ao COVID-19 podemos citar a miocardite / injúria miocárdica, síndrome coronariana aguda, insuficiência cardíaca, arritmias e trombose. Nesta revisão, temos por objetivo resumir as principais evidências sobre estas complicações cardiovasculares associadas à COVID-19.
Referências
AYITTEY, F. K.; AYITTEY, M. K.; CHIWERO, N. B.; KAMASAH, J. S. et al. Economic impacts of Wuhan 2019-nCoV on China and the world. Journal of Medical Virology, v. 92, n. 5, p. 473-475, 2020.
BADAWI, A.; RYOO, S. G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International Journal of Infectious Diseases, v. 49, p. 129-133, 2016.
BANGALORE, S.; SHARMA, A.; SLOTWINER, A.; YATSKAR, L. et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. New England Journal of Medicine, v. 382, n. 25, p. 2478-2480, 2020.
BANSAL, M. Cardiovascular disease and COVID-19. Diabetology & Metabolic Syndrome, v. 14, n. 3, p. 247-250, 2020.
BOOTH, C. M.; MATUKAS, L. M.; TOMLINSON, G. A.; RACHLIS, A. R. et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA, v. 289, n. 21, p. 2801-2809, 2003.
CHAN, J. W.; NG, C. K.; CHAN, Y. H.; MOK, T. Y. et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax, v. 58, n. 8, p. 686-689, Aug 2003.
CHEN, T.; WU, D.; CHEN, H.; YAN, W. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. British Medical Journal, v. 368, p. m1091, 2020.
CONNORS, J. M.; LEVY, J. H. COVID-19 and its implications for thrombosis and anticoagulation. Blood, v. 135, n. 23, p. 2033-2040, 2020.
DE FILIPPO, O.; D'ASCENZO, F.; ANGELINI, F.; BOCCHINO, P. P. et al. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. New England Journal of Medicine, v. 383, n. 1, p. 88-89, 2020.
FRIED, J. A.; RAMASUBBU, K.; BHATT, R.; TOPKARA, V. K. et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation, v. 141, n. 23, p. 1930-1936, 2020.
GARCIA, S.; ALBAGHDADI, M. S.; MERAJ, P. M.; SCHMIDT, C. et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. Journal of the American College of Cardiology, v. 75, n. 22, p. 2871-2872, 2020.
GUAN, W. J.; NI, Z. Y.; HU, Y.; LIANG, W. H. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, n. 18, p. 1708-1720, Apr 30 2020.
GUO, T.; FAN, Y.; CHEN, M.; WU, X. et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, v. 5, n. 7, p. 811-818, 2020.
HUANG, C.; WANG, Y.; LI, X.; REN, L. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, v. 395, n. 10223, p. 497-506, 2020.
KANG, Y.; CHEN, T.; MUI, D.; FERRARI, V. et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart, v. 106, n. 15, p. 1132-1141, 2020.
KUNUTSOR, S. K.; LAUKKANEN, J. A. Cardiovascular complications in COVID-19: A systematic review and meta-analysis. Journal of Infection, v. 81, n. 2, p. e139-e141, 2020.
LAKKIREDDY, D. R.; CHUNG, M. K.; GOPINATHANNAIR, R.; PATTON, K. K. et al. Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation, v. 141, n. 21, p. e823-e831, 2020.
LAUER, S. A.; GRANTZ, K. H.; BI, Q.; JONES, F. K. et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine, v. 172, n. 9, p. 577-582, 2020.
LECHIEN, J. R.; CHIESA-ESTOMBA, C. M.; DE SIATI, D. R.; HOROI, M. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, v. 277, n. 8, p. 2251-2261, 2020.
LIBBY, P.; TABAS, I.; FREDMAN, G.; FISHER, E. A. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Research, v. 114, n. 12, p. 1867-1879, 2014.
LOWENSTEIN, C. J.; SOLOMON, S. D. Severe COVID-19 Is a Microvascular Disease. Circulation, v. 142, n. 17, p. 1609-1611, 2020.
LU, R.; ZHAO, X.; LI, J.; NIU, P. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, v. 395, n. 10224, p. 565-574, 2020.
MEDCALF, R. L.; KERAGALA, C. B.; MYLES, P. S. Fibrinolysis and COVID-19: A plasmin paradox. Journal of Thrombosis and Haemostasis, 2020.
MEHRA, M. R.; RUSCHITZKA, F. COVID-19 Illness and Heart Failure: A Missing Link? JACC Heart Failure, v. 8, n. 6, p. 512-514, 2020.
NISHIGA, M.; WANG, D. W.; HAN, Y.; LEWIS, D. B. et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, v. 17, n. 9, p. 543-558, 2020.
PANIGADA, M.; BOTTINO, N.; TAGLIABUE, P.; GRASSELLI, G. et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. Journal of Thrombosis and Haemostasis, v. 18, n. 7, p. 1738-1742, 2020.
PARANJPE, I.; FUSTER, V.; LALA, A.; RUSSAK, A. J. et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. Journal of the American College of Cardiology, v. 76, n. 1, p. 122-124, 2020.
PEIRIS, J. S.; CHU, C. M.; CHENG, V. C.; CHAN, K. S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, v. 361, n. 9371, p. 1767-1772, 2003.
PRABHU, S. D. Cytokine-induced modulation of cardiac function. Circulation Research, v. 95, n. 12, p. 1140-1153, 2004.
SANDERS, J. M.; MONOGUE, M. L.; JODLOWSKI, T. Z.; CUTRELL, J. B. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA, v. 323, n. 18, p. 1824-1836, 2020.
SHI, S.; QIN, M.; SHEN, B.; CAI, Y. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology, v. 5, n. 7, p. 802-810, 2020.
SIDDIQI, H. K.; MEHRA, M. R. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. Journal of Heart and Lung Transplantation, v. 39, n. 5, p. 405-407, 2020.
TAY, M. Z.; POH, C. M.; RENIA, L.; MACARY, P. A. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, v. 20, n. 6, p. 363-374, 2020.
THYGESEN, K. 'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018. European Heart Journal, v. 40, n. 3, p. 226, 2019.
VARGA, Z.; FLAMMER, A. J.; STEIGER, P.; HABERECKER, M. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet, v. 395, n. 10234, p. 1417-1418, 2020.
WANG, D.; HU, B.; HU, C.; ZHU, F. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, v. 323, n. 11, p. 1061-1069, 2020.
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. Disponível em: https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid-19-- -11-march-2020.
WU, F.; ZHAO, S.; YU, B.; CHEN, Y. M. et al. A new coronavirus associated with human respiratory disease in China. Nature, v. 579, n. 7798, p. 265-269, 2020.
WU, Z.; MCGOOGAN, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, v. 323, n. 13, p. 1239-1242, 2020.
XU, Z.; SHI, L.; WANG, Y.; ZHANG, J. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Medicine, v. 8, n. 4, p. 420-422, 2020.
YONAS, E.; ALWI, I.; PRANATA, R.; HUANG, I. et al. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. American Journal of Emergency Medicine, 2020.
ZHANG, H.; PENNINGER, J. M.; LI, Y.; ZHONG, N. et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, v. 46, n. 4, p. 586-590, 2020.
ZHOU, F.; YU, T.; DU, R.; FAN, G. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, v. 395, n. 10229, p. 1054-1062, 2020.
ZHOU, P.; YANG, X. L.; WANG, X. G.; HU, B. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, v. 579, n. 7798, p. 270-273, 2020.
